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Introduction
Antimicrobial and host defense peptides play a central role in the protection against invading pathogens, providing antimicrobial, anti-inflammatory, as well as other effects (1, 2) . With increasing resistance development against conventional antibiotics, as well as remaining challenges in the treatment of both acute and chronic inflammation, such peptides have been subject of considerable research interest during the last decade. As part of this, various approaches have been employed for identification of potent, but simultaneously selective, peptides, including, e.g., quantitative structure-activity approaches (3) . Within context, we have focused our efforts primarily on peptides derived from endogenous proteins, including complement, coagulation, and matrix proteins, displaying potent antimicrobial effects but also low toxicity to human cells. In addition to such directly antimicrobial effects, some of these studies have also been demonstrated to display potent anti-inflammatory capacity, able to counteract the multiple detrimental effects of bacterial lipopolysaccharide (LPS) from Gramnegative bacteria, as well as related effects from lipoteichoic acid (LTA) from Gram-positive bacteria and zymosan from fungi (4, 5) .
In our work with coagulation-based host defense peptides and holoproteins, we previously investigated the serine proteinase inhibitor heparin cofactor II (HCII), and were able to demonstrate a novel host defense function of this protein (6) . Thus, compared to normal mice,
HCII
-/-knock-outs were found to be more susceptible to LPS-induced shock and invasive infection by Pseudomonas aeruginosa. Concomitantly, a significantly increased cytokine response was observed in HCII -/-mice in response to infection, and HCII levels were reduced in infected normal mice. The LPS-binding, as well as antimicrobial capacity, of activated HCII was furthermore found to be dependent on a conformational change, exposing the amphiphilic and positively charged A and D helices of HCII.
Having shown that these helices are important for the host defense function of HCII, we hypothesized that the epitopes alone could potentially maintain some functional properties of the holoprotein, thus offering interesting opportunities as simpler therapeutic agents. We here describe biological activities of a helix A-derived peptide of HCII, GKS26
(GKSRIQRLNILNAKFAFNLYRVLKDQ), spanning the entire length of the helix. In doing so, we report on its antimicrobial and anti-inflammatory properties, using a battery of assays for broad effect characterization. In parallel, biophysical investigations provided additional insight into the mechanisms underlying these effects. The peptide exerted potent antibacterial and anti-inflammatory activities, and showed efficiency in a model of endotoxin-induced shock in vivo. Taken together, the results thus demonstrate this peptide to be of potential interest in the development of novel anti-infective and anti-inflammatory therapies.
Experimental
Chemicals. GKS26 (Table 1) was synthesized by Biopeptide Co., San Diego, USA, and was of >95% purity, as evidenced by mass spectral analysis (MALDI-TOF Voyager). LPS and lipid A from E. coli (0111:B4 and F583 (Rd mutant), respectively) were from Sigma (St.
Louis, USA). In LPS (>500000 EU/mg), protein and RNA content were both less than 1%. respectively. For measurements in the presence of LPS, 0.2 mg/ml was used. To account for instrumental differences between measurements, background subtraction was performed routinely. Signals from the bulk solution were also corrected for.
Microorganisms
Ellipsometry. Peptide adsorption to supported lipid bilayers was studied in situ by null ellipsometry, using an Optrel Multiskop (Optrel, Kleinmachnow, Germany) equipped with a 100 mW Nd:YAG laser (JDS Uniphase, Milpitas, USA). All measurements were carried out at 532 nm and an angle of incidence of 67.66° in a 5 ml cuvette under stirring (300 rpm). Both the principles of null ellipsometry and the procedures used have been described extensively before (9) . In brief, measurements were first made on the bare silica surface, which allows its complex refractive index to be determined. These parameters were subsequently used together with new sets of the optical component positions after adsorbed layer formation for determining the thickness and refractive index of the adsorbed layer. From this, the mean 8 refractive index (n) and layer thickness (d) of the adsorbed layer can be obtained. From the thickness and refractive index the adsorbed amount () was calculated according to:
where n 0 is the refractive index of the bulk solution, and dn/dc the refractive index increment (supporting the lipid bilayer) and a lower reference waveguide. The changes induced by the peptide/lipid adsorption was monitored through changes in the transverse electric and transverse magnetic modes as described previously (12) . As for ellipsometry, Eq. 1 was used for determining the mass adsorbed. Although treating phospholipids as optically isotropic systems is a reasonably accurate approximation for unsaturated and disorganized phospholipid bilayers, these actually display some optical birefringence, which is measurable with the sensitive DPI technique. DPI allows two parameters to be obtained from each measurement, e.g., for the simultaneous determination of two optical parameters of the adsorbed layer. The latter were chosen to be the adsorbed amount and the anisotropy, assuming the adsorbed layer thickness to be constant during the adsorption process. The birefringence (n f ), obtained from the refractive indices for the TM and TE waveguide modes, reflects ordering of the lipid molecules in the bilayer, and decreases with increasing disordering of the bilayer (13) . Consequently, n f can be used to monitor disordering transitions in lipid bilayers, e.g., as a result of peptide binding and incorporation, and therefore offers a simpler alternative to, e.g., order parameter analyses in 2 H-NMR spectroscopy (14) . In the present study, DOPE/DOPG liposomes (75/25 mol/mol) were prepared as described above for ellipsometry, and the liposomes (at a lipid concentration of 0.2 mg/ml in 10 mM HEPES buffer, containing also 150 mM NaCl and 1.5 mM CaCl 2 ) fused to the silicon oxynitride/silicon substrate (contact angle <5°) at a flow rate of 25 L/min for 8
minutes. This resulted in bilayer formation, characterized by a refractive index of 1.47, a thickness of 4.5±0.3 nm, and an area per molecule of 54 Å 2 . After bilayer formation, the buffer was changed to 10 mM Tris buffer, allowing continous flushing (at flow rate, 50 l/ min) for 10 minutes, after which peptide was added at the desired concentration. Peptide adsorption was monitored for one hour. Measurements were performed at least in duplicate at 25°C.
Radial diffusion assay. Essentially as described before (15, 16) , bacteria were grown to midlogarithmic phase in 10 ml of full-strength (3% w/v) trypticase soy broth (TSB) (Becton- 
Histochemistry. Organs were collected 20 h after LPS injection and immediately fixed in 4%
formaldehyde (Histolab AB, Göteborg, Sweden) prior to paraffin embedding and sectioning.
Sections were stained with Mayers Haematoxylin (Histolab AB, Göteborg, Sweden) and Eosin (Merck). 
Results
GKS26 is antimicrobial in vitro and ex vivo. First, radial diffusion (RDA) and viable count
(VCA) assays were performed to probe direct bactericidal effects of GKS26. As shown in Figure 1A and B, GKS26 displays potent antimicrobial effects against Gram-negative E. coli and P. aeruginosa, as well as Gram-positive S. aureus and B. subtilis. Furthermore, Figure 1C demonstrates similar kinetics of this effect for E. coli and P. aeruginosa. While some of the antimicrobial activity is lost in the presence of serum, high antimicrobial activity is observed in the presence of CP ( Figure 1B ). The latter is noteworthy, since binding of cationic AMPs to net negatively charged serum proteins frequently results in considerable loss in antimicrobial effects (8) . The finding that plasma even accentuates the antimicrobial effects demonstrates that fibrinogen and other coagulation factors may in fact contribute to bactericidal effects, presumably through membrane interactions of highly surface active fibrinogen (18, 19) .
Adding to this, Figure 2 shows GKS26 to display pronounced selectivity between bacteria and mammalian cells. Thus, for P. aeruginosa and E. coli added to human blood, the peptide is able to potently kill bacteria, but at the same time not cause hemolysis much above that of the negative control. For S. aureus, this selectivity in blood is less pronounced.
GKS26 interacts with bacterial lipid membranes.
As demonstrated by peptide-induced release of intracellular material, as well as by FITC permeation, the antimicrobial effect of GKS26 is caused by bacterial membrane lysis ( Figure 3A Importantly, there is no threshold for membrane insertion. Instead, the DPI results clearly reports on a continuous process, where all peptides bound to the membrane are inserted into the membrane (as opposed to sitting on-top), throughout the binding process, undergoing modest conformational changes in the process ( Figure 5C ).
GKS26 interacts with bacterial lipopolysaccharide and reduces LPS responses in vitro,
ex vivo, and in vivo. Moreover, GKS26 displays extensive binding to both E. coli LPS and its endotoxic lipid A moiety ( Figure 6A ), causing a pronounced structure transition in the LPS/peptide complex ( Figure 6B ). As shown in Figure 4 , GKS26 binds preferentially to LPS over the lipid membrane. In previous reports it has been shown that binding to LPS, especially the lipid A moiety, is a prerequisite for anti-inflammatory effects of amphiphilic peptides (20) . Therefore, experiments were performed to investigate whether this is the case also for GKS26. Studies using mouse macrophages revealed that GKS26 dose-dependently reduced the LPS-induced production of nitric oxide ( Figure 7A ). After recognition of LPS via the TLR4-MD2 complex, a signaling cascade is initiated leading to the activation of NF-B and finally to cytokine production and release (21) (22) (23) . In experiments using a NF-B reporter cell line (RAW Blue cells), the data show that GKS26 significantly reduces NF-B activation ( Figure 7B ). Moreover the data reveal that this inhibition depends on the ratio of LPS and peptide, indicating that direct LPS scavenging is indeed important for this effect by GKS26. This is further supported by data from a LDH assay, showing no toxic effects of the peptide on RAW-Blue cells ( Figure 7C ), thus the reduction is at least partly due to LPS-GKS26 interactions and not due to toxicity. Moreover these LDH data are consistent with reduced toxicity seen in blood ( Figure 2B ). Finally, effects of GKS26 on LPS-induced cytokine release were determined ex vivo using a whole blood model. The data show that GKS26 reduced the pro-inflammatory cytokines TNF-α and IL-6, but had no effect on antiinflammatory IL-10 release ( Figure 7D ).
Having demonstrated potential anti-inflammatory effects of GKS26 in vitro, but also ex vivo, a next set of experiments was performed to investigate those in an in vivo context. C57BL/6 mice were challenged with 18 mg/kg E. coli LPS and treated with either 200 μg of 500 μg of GKS26. Consistent with the data of the whole blood experiments, GKS26 treatment resulted in a dose-dependent reduction of the pro-inflammatory cytokines IL-6, TNF-, MCP-1, and IFN-, as well as in IL-10 ( Figure 7E ). In parallel, peptide treatment improved the overall status of these animals as illustrated by improved health scoring ( Figure 7F ).
Inflammation is an important initiator of coagulation (24) . Furthermore, systemic activation of coagulation is a compromising factor in sepsis, characterized by consumption of coagulation factors and excessive fibrinolysis, leading to e.g. prolonged coagulation times and thrombocytopenia in patients (25) . Compatible to these symptoms are results on platelet levels, as well as clotting times in mice challenged with LPS ( Figure 7G and H). The latter displayed prolonged clotting times and a significant reduction in platelets, in contrast to mice treated with GKS26, which showed normalization of both the activated partial thromboplastin time (aPTT) and the prothrombin time (PT) ( Figure 7G ), as well less partial recovery of platelet numbers ( Figure 7H ). Examination of mouse lungs further revealed a reduction of disease symptoms, as illustrated by reduced vascular leakage, infiltration of inflammatory and red blood cells, and less reduction in alveolar space for peptide-treated animals compared to LPS-treated ones ( Figure 7I ), effects particularly clear at the higher concentration of GKS26.
Taken together, these findings demonstrate that treatment with GKS26 dampened a range of sepsis-associated pathologies, including the release of pro-inflammatory cytokines, vascular leakage, excessive coagulation, as well as platelet consumption.
Discussion
With its high net charge and intermediate hydrophobicity ( (27) , as well as peptides derived from S1
peptidases at DOPE/DOPG bilayers (28) . As a result of peptide insertion into the lipid membrane, the latter is destabilized, illustrated by peptide-induced liposome leakage.
Importantly, there is a clear correlation between peptide binding density/insertion, destabilization of both model DOPE/DOPG liposomes and liposomes composed of E. coli lipid extract, and bacteria lysis, the latter in turn causing bactericidal effects. Importantly, however, GKS26 displays selectivity between bacteria and human cells, demonstrated by the combined bactericidal and hemolysis assays on blood supplemented with bacteria. Such selectivity has previously been observed, e.g., for highly charged and simultaneously moderately hydrophobic peptides (29) , and is due to lower peptide binding caused by the lower charge density of the human cell membranes, combined with resistance to peptide insertion caused by the presence of cholesterol.
LPS is a negatively charged lipopolysaccharide, anchored to the outer membrane in Gramnegative bacteria through its hydrophobic lipid A moiety (20) . Thus, peptides can reach anti-endotoxic effects also through causing disruption of LPS aggregates (27, 31, 32) . Mirroring this, it was recently demonstrated that peptide-induced LPS disaggregation is correlated to pronounced structure transition in the LPS/peptide complex (27, 28) , as presently observed for GKS26. is caused by direct membrane rupture, where the peptide binds at high density to the lipid membrane, insert into this without insertion threshold, and destabilize the membrane (27 
Conclusions
The peptide GKS26, derived from the A domain of HCII, displays potent antimicrobial effects, also at physiological salt concentration and in the presence of plasma and serum, mice was induced by intraperitoneal (ip) injection of E. coli LPS (18 mg/kg) followed by ip
